Dr. Steven Nissan and his colleague sorted through a study conducted by GSK on Avandia's safety, and found that the drug significantly increased a patient's risk for heart disease.
Because Europe is still more interested in protecting their citizens and the FDA is more interested in protecting the profits of Big Pharma, as usual.
~
1 comment:
SO DOES MOBIC AND CELEBREX. THE US DID TAKE VIOXX OF THE MARKET...I WAS ON THAT WHEN I HAD THE CHEST PAIN ON THE PLANE GOING TO MICHIGAN.
NOW I'M ON MOBIC, AND HAVE HAD ANOTHER MINI STROKE. TODAY I STOP IT ON MY OWN.
Post a Comment